In recent years, researchers have shown a special interest in the role of signaling pathways as disease molecular targets and capitalized on such pathways to derive natural products, biologics, and synthetic scaffold-based prevention and treatments. These can lead to naturally available, efficacious, low-cost, and minimally toxic long-term therapies for human diseases. This Special Issue of Cells comprises an array of literature reviews, original communications, and studies on the roles of the PI3K/AKT/mTOR and associated pathways in a diversity of pathways using in vitro cell-based assays and preclinical animal models. The authors of the papers also explore technologies designed to improve the bioavailability and delivery of certain compounds. In lieu of ongoing research on a variety of human disorders, the wealth of information published in this Special Issue can act as a springboard for the identification of novel disease targets and the development of new preventive and therapeutic modalities for the management of human diseases.
Bitte wählen Sie Ihr Anliegen aus.
Rechnungen
Retourenschein anfordern
Bestellstatus
Storno







